CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Organika AO is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Organika AO
shosse Kuznetskoye, 3
Phone: +7 3843994222p:+7 3843994222 NOVOKUZNETSK, 654034  Russian Federation Ticker: orgnorgn
Business Summary
Organika AO is a Russia-based pharmaceutical company specializing in the manufacture of pharmaceutical substances and finished medicinal products. The Company develops and produces prescription and non-prescription medicines in solid and liquid dosage forms, serving a broad range of therapeutic areas, including cardiovascular, neurological, psychiatric, analgesic, anesthetic, and other medical treatments. Its activities include pharmaceutical research collaboration, product portfolio development, manufacturing of active pharmaceutical ingredients, and production of finished drug formulations for the healthcare sector. The Company also maintains cooperation with scientific and research institutions to support the development and introduction of pharmaceutical products.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Advisor Anatoly E.Vinogradov 48
General Director (CEO), Director Andrey P.Lyangus 58 1/1/2008
Director, Technical Director Fedor V.Guss 72 1/1/2001
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 980 (As of 12/31/2024)
Outstanding Shares: 149,852 (As of 12/31/2025)
Shareholders: 504
Stock Exchange: RTB
Fax Number: +7 3843994200


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 25, 2026